Inadequate Encryption Strength Vulnerability in Roche Algo Edge

published 2025-01-17 21 mo ago modified 2026-06-17 4 mo ago also EUVD-2024-51283

cvss: 6.1; version 4.0, CNA
cisa kev: Not listed; not in CISA's catalog
epss: 0.1%; EPSS 0.1% chance of exploitation in 30 days, percentile 2%
public exploits: 0; none known

A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.

Patch / fix

fixed in 1

Roche Diagnostics Algorithm Suite 2.1.2

CISA SSVC

Exploitation: none
Automatable: no
Technical impact: total
Assessed: 21 mo ago (2025-01-17)

Exploit prediction

0.13% chance of exploitation in the next 30 days, higher than 2% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by	version	score	vector
CNA	4.0	6.1	CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/S:N/AU:N/R:A/V:D/RE:L/U:Clear
CNA	4.0	6.1	CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:N/R:A/V:D/RE:L/U:Clear

Affected products

Roche Diagnostics Algorithm Suite

Classification

Weakness

CWE-326 Inadequate Encryption Strength

References

diagnostics.roche.com /content/dam/diagnostics/Blueprint/en/pdf/Algo%20Edge%20-%20Authentication%20Vulnerability%20-%20Product%20Sec
vendor-advisory

Sources

CVE List CVE-2024-13026
NVD CVE-2024-13026

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

Summary